You learn something every day. Today I heard about the German NUB regulation, which has some features of CED.
It stands for Neue Untersuchungs- und Behandlungsmethode : New Investigation & Therapies Methods, basically.
NUB was introduced after Germany discovered post 2003 that its DRG inpatient system made it hard for hospitals to innovate. (USA Medicare has a "New Technology Add-on Payment" or NTAP for our DRG system.)
It's a more hospital-based system in which a hospital can contract for one year or two of special payment for a new device while data is collected. The device must be CE marked and used less than 3 years in Germany and cost > €500.
NUB Sources
- Sebastian Gaiser, formerly with St Jude, now at J&J, has a 14 slide deck from 2014 about the NUB system available open access on line. It's not entirely in favor of NUB, and sees flaws, but gives you an introduction. Here.
- See also a 19 page, 2009 deck about NUB from Henschke et al., here.
- The group "Assessment in Medicine" has a 24 page PDF from 2017 that discusses NUB. Here.
- Cloud zip file for the above, here.
Once you've heard of NUB, you start to see it in press releases, e.g. this 2018 press release for the BIOVENTRIX transcatheter device.
There seems to be another German system called "137E" which I've seen cited as supporting rollout of cancer drugs, e.g. here. See also a 2014 article by Olberg et al. on CED/137E in Germany, here. NUB is a limited DRG focused program, 137E is a broader CED concept.
___
Hoffman et al. have just an conference abstract on NUB in Value in Health 2016. Here.
ISPOR has a 2011 detailed webpage on the whole complexity of the German System (includes a bit on NUB). Here.
The 24-page Assessment in Medicine (AIM) document is on the website of IGES, a technology institute that may be a university spinout, here.
The 24-page Assessment in Medicine (AIM) document is on the website of IGES, a technology institute that may be a university spinout, here.
The main German health technology assessment group is called IQWiG, here.